Vidutolimod sodium

• CAT Number: I040321
• Molecular Weight: 10301.90
• Purity: ≥95%

Vidutolimod sodium(CAT: I040321) is a synthetic CpG-A oligodeoxynucleotide encapsulated within a virus-like particle (VLP) designed to activate Toll-like receptor 9 (TLR9), a key receptor involved in innate immune sensing of unmethylated CpG DNA motifs. As a potent TLR9 agonist, Vidutolimod stimulates type I interferon production, enhances dendritic cell activation, and promotes antitumor immune responses. It is under investigation for intratumoral immunotherapy in solid tumors, particularly in combination with immune checkpoint inhibitors. The sodium salt form enhances formulation stability and delivery. Vidutolimod sodium is a valuable agent for immuno-oncology and tumor microenvironment research.